Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
35.44 USD | +0.55% | -0.87% | -8.33% |
May. 13 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.33% | 17.96B | |
-4.97% | 181B | |
+2.74% | 112B | |
-2.72% | 67.92B | |
+4.54% | 50.1B | |
+8.00% | 44.27B | |
+9.39% | 40.41B | |
+25.27% | 31.95B | |
+0.01% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 10